Last update 01 Nov 2024
Pioglitazone Hydrochloride/Sitagliptin Phosphate Monohydrate
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Janacti, Pioglitazine/sitagliptin, Sitagliptin/pioglitazone + [2] |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC19H21ClN2O3S |
InChIKeyGHUUBYQTCDQWRA-UHFFFAOYSA-N |
CAS Registry112529-15-4 |
View All Structures (2)
Related
1
Clinical Trials associated with Pioglitazone Hydrochloride/Sitagliptin Phosphate MonohydrateDPP-4 Inhibition and Thiazolidinedione for Diabetes Mellitus Prevention (DInT DM Study)
100 Clinical Results associated with Pioglitazone Hydrochloride/Sitagliptin Phosphate Monohydrate
Login to view more data
100 Translational Medicine associated with Pioglitazone Hydrochloride/Sitagliptin Phosphate Monohydrate
Login to view more data
100 Patents (Medical) associated with Pioglitazone Hydrochloride/Sitagliptin Phosphate Monohydrate
Login to view more data
100 Deals associated with Pioglitazone Hydrochloride/Sitagliptin Phosphate Monohydrate
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | NDA/BLA | EU | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | - | 20 | ojhapmyuzu(gdlivyuhuw) = ujeppmkclv fijnqlvtpc (fbbvljxxyx ) View more | - | 01 Jun 2021 | ||
Placebo | ojhapmyuzu(gdlivyuhuw) = qotswfwuvz fijnqlvtpc (fbbvljxxyx ) View more | ||||||
Not Applicable | 3 | (Sitagliptin + Pioglitazone PLACEBO) | bdsxkckhbb(fbeucxokjj) = cvkdfowfpr uenzrrgnic (uelywhshab, kyelmubdae - pjszlfhsnw) View more | - | 07 Jun 2013 | ||
(Sitagliptin + Pioglitazone) | bdsxkckhbb(fbeucxokjj) = ndhqpxxtny uenzrrgnic (uelywhshab, tnmqcfvfcs - brmdopfase) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free